UY23672A1 - Procedimiento para la preparacion de derivados de cefalosporina - Google Patents

Procedimiento para la preparacion de derivados de cefalosporina

Info

Publication number
UY23672A1
UY23672A1 UY23672A UY23672A UY23672A1 UY 23672 A1 UY23672 A1 UY 23672A1 UY 23672 A UY23672 A UY 23672A UY 23672 A UY23672 A UY 23672A UY 23672 A1 UY23672 A1 UY 23672A1
Authority
UY
Uruguay
Prior art keywords
preparation
hydrate
salt
pharmaceutically acceptable
compound
Prior art date
Application number
UY23672A
Other languages
English (en)
Inventor
Dennis Dalto Keith
Chung-Chen We
Scott Louis Dax
Pamela Loreen Rossman
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of UY23672A1 publication Critical patent/UY23672A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Procedimiento para la preparación de derivados de cefalosporina de fórmula general (I) (figura 1), y ésteres fácilmente hidrolizables y farmacéuticamente aceptables correspondientes así como sales e hidratos de estos compuestos, donde R representa uno de los grupos representados en la figura 2; el procedimiento comprende: a- acilar un compuesto de fórmula general (II) (figura 3), donde R' es un grupo correspondiente a R que comporta un grupo amino insustituido en posición 7 del núcleo cefalosporínico, o una sal de adición de ácido respectiva; b- o bien convertir un compuesto de fórmula (I) en una sal o hidrato o hidrato de dicha sal farmacéuticamente aceptable. Ejemplo no limitante: ácido (6R-trans)-3-hidroximetil-7-[[(1,1-dimetil-etoxi-carbonil]amino]-8-oxo-5-tia-1-azabiciclo[4.2.0]oct-2-en-2-carboxílico. Los productos finales conforme al procedimiento son de utilidad en la preparación de un medicamento para el tratamiento y profilaxis de enfermedades infecciosas.
UY23672A 1992-11-12 1993-11-12 Procedimiento para la preparacion de derivados de cefalosporina UY23672A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97625092A 1992-11-12 1992-11-12
US97624892A 1992-11-12 1992-11-12

Publications (1)

Publication Number Publication Date
UY23672A1 true UY23672A1 (es) 1994-05-06

Family

ID=27130586

Family Applications (1)

Application Number Title Priority Date Filing Date
UY23672A UY23672A1 (es) 1992-11-12 1993-11-12 Procedimiento para la preparacion de derivados de cefalosporina

Country Status (19)

Country Link
EP (1) EP0597303A2 (es)
JP (1) JPH06199868A (es)
KR (1) KR940011470A (es)
CN (1) CN1141922A (es)
AU (1) AU5051793A (es)
BG (1) BG98208A (es)
BR (1) BR9304699A (es)
CA (1) CA2108609A1 (es)
CZ (1) CZ239893A3 (es)
FI (1) FI935025A (es)
HU (1) HUT65717A (es)
IS (1) IS4093A (es)
LV (1) LV10277A (es)
MX (1) MX9306985A (es)
NO (1) NO934078D0 (es)
PL (1) PL301024A1 (es)
SI (1) SI9300555A (es)
SK (1) SK125693A3 (es)
UY (1) UY23672A1 (es)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT49889A (en) * 1988-03-31 1989-11-28 Hoffmann La Roche Process for producing acyl derivatives
EP0997466A1 (en) * 1988-10-24 2000-05-03 PROCTER & GAMBLE PHARMACEUTICALS, INC. Novel antimicrobial lactam-quinolones

Also Published As

Publication number Publication date
JPH06199868A (ja) 1994-07-19
HUT65717A (en) 1994-07-28
NO934078L (es) 1994-05-13
IS4093A (is) 1994-05-13
CN1141922A (zh) 1997-02-05
KR940011470A (ko) 1994-06-21
BR9304699A (pt) 1994-06-14
NO934078D0 (no) 1993-11-11
FI935025A (fi) 1994-05-13
LV10277A (lv) 1994-10-20
BG98208A (en) 1994-05-27
AU5051793A (en) 1994-05-26
SK125693A3 (en) 1994-09-07
MX9306985A (es) 1995-01-31
CZ239893A3 (en) 1994-06-15
FI935025A0 (fi) 1993-11-12
CA2108609A1 (en) 1994-05-13
PL301024A1 (en) 1994-05-16
SI9300555A (en) 1994-06-30
EP0597303A2 (en) 1994-05-18
EP0597303A3 (es) 1994-08-03

Similar Documents

Publication Publication Date Title
ES2095059T3 (es) Productos intermedios en un procedimiento para la purificacion de acido clavulanico.
ES8703881A1 (es) Procedimiento para la fabricacion de derivados del acido &- (oxo-2 hexahidro-2,4,5,6,7,7a tieno (3,2-c)piridil-5) fenil acetico
GB1069343A (en) Propanolamine derivatives
CZ158695A3 (en) Pyrazolopyrimidine compounds as such and for treating diseases and pharmaceutical preparations based thereon
UY23757A1 (es) Procedimiento para la preparación de derivados de cefalosporina.-
GB1363506A (en) Process for the preparation of alpha-amino-penicillins and such penicillins and intermediates and pharmaceutical preparations
NO177934C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive kinolinkarboksylsyrederivater
YU224790A (sh) Aminokarbonil karbamati, sorodni fizostigminu/in postopek za njihovo pripravo in njihova uporaba kot zdravila
SE7907764L (sv) 3-osubstituerade 3-cefemforeningar
DE69319296D1 (de) Verfahren zur Reinigung von roher Clavulansäure
UY23672A1 (es) Procedimiento para la preparacion de derivados de cefalosporina
ES431497A1 (es) Procedimiento para preparar un derivado de s-triazol (1,5- a) piridina.
ES2001852A6 (es) Procedimiento para preparar un derivado de acido quinolocarboxilico
AR008371A1 (es) Una sal de adicion con acido de una 10-aminoalifatil-dibenz[b,f],oxepina, su empleo; procedimiento para su elaboracion, una 10-aminoalifatil-dibenz[b,f]oxepina, una preparacion farmaceutica que contiene dicha sal o dicha oxepina y un procedimiento para el tratamiento de enfermedades neurodegenerativ
DE2963010D1 (en) 3-chloro-6-hydroxy-5-methylbenzoic acid derivatives, corresponding pharmaceutical preparations, growth promoting compositions, the use of the compounds for promoting growth in certain animals and their manufacture
JPS62221659A (ja) アミノ置換安息香酸
DE3884508D1 (de) Cystein-derivate mit expectorans-wirkung.
FI97883B (fi) Menetelmä lääkeaineena käyttökelpoisen glyserolijohdannaisen valmistamiseksi
ES2031833T3 (es) Procedimiento para la obtencion de nuevos arilmetoxitiofenoderivados nitrogenados.
NO163133C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktiv 5r, 6s, 8r-6-(1-hydroxyethyl)-2-(2-carbamoyloxy-ethylthio)-penem-3-carboxylsyre.
HU171232B (hu) Sposob poluchenija proizvodnykh 7-kvadratnaja skobka-skobka-2-aminometil-fenil-skobka zakrita-acetamido-kvadratnaja skobka zakryta-3-tiadiazolil-tiometil-cef-3-em-4-karbonovojj kisloty
CS203008B2 (en) Process for preparing acylderivatives
CO4410188A1 (es) Derivados novedosos del acido propanoico
UY23510A1 (es) Procedimiento para la preparacion de derivados de la cefalosporina
ES520955A1 (es) Procedimiento para la obtencion de 7-alfa aminoacil-3-clorocefaloesporinas.